Kipp Bodnar (HubSpot’s CMO) and Kieran Flanagan (Zapier’s CMO), lead you down the rabbit hole of marketing trends, growth tactics and innovation. On the way you’ll pick up undiscovered strategies to give you that slight edge for success. These are not your typical twitter thread regurgitated marketing tactics that everyone is doing. These are new methods, with unfiltered examination of successful fresh ideas.
…
continue reading
Contenuto fornito da eric@hoosieragtoday.com. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da eric@hoosieragtoday.com o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
308. Biodyne USA’s Bodie Kitchel on the economics of biologicals, the pursuit of answers + innovating with urgency
Manage episode 426576694 series 1412285
Contenuto fornito da eric@hoosieragtoday.com. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da eric@hoosieragtoday.com o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Biologicals – the broad category of ag input products derived from living organisms – have experienced significant growth in terms of adoption and investment. An analysis of Pitchbook data reveals there have been more than 6,000 deals in the global ag biotech market over the past decade. One of those companies driving growth is Biodyne USA. This week, we are joined by their National Director of Agronomy, Bodie Kitchel, to talk Biologicals vs. Biostimulants and what’s driving growth in the space. For Bodie, everyone’s “why” looks a little different when it comes to the adoption of biologicals and farm economics are certainly a piece of that. He gets into the farmer mindset around adopting innovation to leverage net farm income and Biodyne being an education company to help farmers learn where their dollar has the most value. Bodie also talks about needing economic impact right away but also balancing that belief with the value of economic impact in years two, three, four and five. With his experience in ag retail, how has Bodie seen innovation evolve? He talks about positioning, investment and companies being afraid of the unknown. Looking ahead, Bodie talks about that fear being outweighed by the urgency around innovating – and Biodyne USA doing it with speed.
…
continue reading
313 episodi
Manage episode 426576694 series 1412285
Contenuto fornito da eric@hoosieragtoday.com. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da eric@hoosieragtoday.com o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Biologicals – the broad category of ag input products derived from living organisms – have experienced significant growth in terms of adoption and investment. An analysis of Pitchbook data reveals there have been more than 6,000 deals in the global ag biotech market over the past decade. One of those companies driving growth is Biodyne USA. This week, we are joined by their National Director of Agronomy, Bodie Kitchel, to talk Biologicals vs. Biostimulants and what’s driving growth in the space. For Bodie, everyone’s “why” looks a little different when it comes to the adoption of biologicals and farm economics are certainly a piece of that. He gets into the farmer mindset around adopting innovation to leverage net farm income and Biodyne being an education company to help farmers learn where their dollar has the most value. Bodie also talks about needing economic impact right away but also balancing that belief with the value of economic impact in years two, three, four and five. With his experience in ag retail, how has Bodie seen innovation evolve? He talks about positioning, investment and companies being afraid of the unknown. Looking ahead, Bodie talks about that fear being outweighed by the urgency around innovating – and Biodyne USA doing it with speed.
…
continue reading
313 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.